Simulations Plus Gestione
Gestione criteri di controllo 3/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Shawn O'Connor
Amministratore delegato
US$1.9m
Compenso totale
| Percentuale dello stipendio del CEO | 25.1% |
| Mandato del CEO | 6.4yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 3.9yrs |
| Durata media del Consiglio di amministrazione | 3.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We Think Simulations Plus' (NASDAQ:SLP) Healthy Earnings Might Be Conservative
Nov 07
Simulations Plus: Declining Margins Are A Problem
Aug 22Simulations Plus: Steady Growth, But What About The Margins?
Jul 10Simulations Plus: Reliance On Consulting And Acquisitions Creates Doubts
May 14Why We're Not Concerned About Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price
Mar 29Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal
Feb 09Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI
Feb 01We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit
Jan 12Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal
Nov 06Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)
Sep 06Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital
Jun 28Some Investors May Be Worried About Simulations Plus' (NASDAQ:SLP) Returns On Capital
Feb 10With EPS Growth And More, Simulations Plus (NASDAQ:SLP) Makes An Interesting Case
Nov 23A Look At The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)
Oct 21Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital
Sep 19Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Aug 31 2024 | n/a | n/a | US$10m |
| May 31 2024 | n/a | n/a | US$10m |
| Feb 29 2024 | n/a | n/a | US$11m |
| Nov 30 2023 | n/a | n/a | US$11m |
| Aug 31 2023 | US$2m | US$487k | US$10m |
| May 31 2023 | n/a | n/a | US$10m |
| Feb 28 2023 | n/a | n/a | US$10m |
| Nov 30 2022 | n/a | n/a | US$11m |
| Aug 31 2022 | US$1m | US$450k | US$12m |
| May 31 2022 | n/a | n/a | US$12m |
| Feb 28 2022 | n/a | n/a | US$12m |
| Nov 30 2021 | n/a | n/a | US$10m |
| Aug 31 2021 | US$1m | US$444k | US$10m |
| May 31 2021 | n/a | n/a | US$12m |
| Feb 28 2021 | n/a | n/a | US$11m |
| Nov 30 2020 | n/a | n/a | US$10m |
| Aug 31 2020 | US$739k | US$350k | US$9m |
| May 31 2020 | n/a | n/a | US$9m |
| Feb 29 2020 | n/a | n/a | US$9m |
| Nov 30 2019 | n/a | n/a | US$9m |
| Aug 31 2019 | US$425k | US$325k | US$9m |
| May 31 2019 | n/a | n/a | US$8m |
| Feb 28 2019 | n/a | n/a | US$7m |
| Nov 30 2018 | n/a | n/a | US$9m |
| Aug 31 2018 | US$618k | US$54k | US$9m |
Compensazione vs Mercato: La retribuzione totale di Shawn ($USD 1.94M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 2.16M ).
Compensazione vs guadagni: La retribuzione di Shawn è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Shawn O'Connor (64 yo)
6.4yrs
Mandato
US$1,942,004
Compensazione
Mr. Shawn M. O'Connor has been Chief Executive Officer of Simulations Plus, Inc. since June 26, 2018. Mr. Shawn M. O'Connor joined Simulations Plus, Inc. in June 2018. Mr. O'Connor served as Chief Executiv...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Chairman | 28.3yrs | US$199.99k | 17.25% $ 95.5m | |
| Chief Executive Officer | 6.4yrs | US$1.94m | Nessun dato | |
| COO, CFO & Secretary | 3.9yrs | US$880.90k | 0.010% $ 57.9k | |
| President of PBPK & Cheminformatics Solutions | 1.4yrs | US$728.14k | 0.40% $ 2.2m | |
| President of Clinical Pharmacology & Pharmacometrics Services | 5.1yrs | US$722.10k | 0.34% $ 1.9m | |
| Accounting Manager | no data | Nessun dato | Nessun dato | |
| Chief Science Officer | 4.2yrs | Nessun dato | Nessun dato | |
| VP of Corporate Counsel & Personal Data Protection Officer | no data | Nessun dato | Nessun dato | |
| Marketing Manager | less than a year | Nessun dato | Nessun dato | |
| Executive Director of Human Resources | 2.8yrs | Nessun dato | Nessun dato | |
| Chief Science Officer - Quantitative Systems Pharmacology | no data | Nessun dato | Nessun dato | |
| President of Clinical Pharmacology & Pharmacometrics Solutions | no data | Nessun dato | Nessun dato |
3.9yrs
Durata media
60yo
Età media
Gestione esperta: Il team dirigenziale di SLP è considerato esperto (durata media dell'incarico 3.9 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Chairman | 28.3yrs | US$199.99k | 17.25% $ 95.5m | |
| lead Independent Director | 7.5yrs | US$199.99k | 0.040% $ 220.3k | |
| Independent Director | 5.5yrs | US$189.99k | 0.039% $ 215.1k | |
| Member of Scientific Advisory Board | 3.7yrs | Nessun dato | Nessun dato | |
| Chairman of Scientific Advisory Board | 3.7yrs | Nessun dato | Nessun dato | |
| Independent Director | 9.9yrs | US$199.99k | 0.026% $ 145.6k | |
| Member of Scientific Advisory Board | 3.7yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 3.7yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 3.7yrs | Nessun dato | Nessun dato | |
| Independent Director | 2.9yrs | US$187.49k | 0.039% $ 216.8k |
3.7yrs
Durata media
70yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SLP sono considerati esperti (durata media dell'incarico 3.7 anni).